Finally, the positive control, the hydroxamate-based MMP inhibitor NNGH [46], showed IC50 values of 29–187 mM for antiproliferation activities against various cancer cell lines, and against MMP-2 and MMP-9 showed values of 0.0091 and 0.0088 mM, respectively. This evidence concerns the gene MMP9 and cancer.